4//SEC Filing
Reardon Tighe 4
Accession 0001209191-24-000435
CIK 0001817713other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:52 PM ET
Size
5.6 KB
Accession
0001209191-24-000435
Insider Transaction Report
Form 4
Reardon Tighe
Acting Chief Financial Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2024-01-02+157,000→ 157,000 totalExercise: $11.02Exp: 2034-01-01→ Common Stock (157,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on January 1, 2025 and the balance will vest in equal monthly installments thereafter over a three year period.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0001760431
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:52 PM ET
- Size
- 5.6 KB